BR112019018646A2 - método para manter os níveis fisiológicos de tiossulfato, método para prevenir enfarte do miocárdio, método para prevenir morte súbita cardíaca, método para prevenir acidente vascular cerebral, método para prevenir doenças cardiovasculares, método para prevenção de pressão alta, método para prevenir a aterosclerose - Google Patents

método para manter os níveis fisiológicos de tiossulfato, método para prevenir enfarte do miocárdio, método para prevenir morte súbita cardíaca, método para prevenir acidente vascular cerebral, método para prevenir doenças cardiovasculares, método para prevenção de pressão alta, método para prevenir a aterosclerose Download PDF

Info

Publication number
BR112019018646A2
BR112019018646A2 BR112019018646-8A BR112019018646A BR112019018646A2 BR 112019018646 A2 BR112019018646 A2 BR 112019018646A2 BR 112019018646 A BR112019018646 A BR 112019018646A BR 112019018646 A2 BR112019018646 A2 BR 112019018646A2
Authority
BR
Brazil
Prior art keywords
thiosulfate
approximately
dialysate
enriched
subject
Prior art date
Application number
BR112019018646-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Sherman Craig
Original Assignee
Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals filed Critical Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals
Publication of BR112019018646A2 publication Critical patent/BR112019018646A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1656—Apparatus for preparing dialysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112019018646-8A 2017-03-08 2018-03-06 método para manter os níveis fisiológicos de tiossulfato, método para prevenir enfarte do miocárdio, método para prevenir morte súbita cardíaca, método para prevenir acidente vascular cerebral, método para prevenir doenças cardiovasculares, método para prevenção de pressão alta, método para prevenir a aterosclerose BR112019018646A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762468871P 2017-03-08 2017-03-08
US62/468,871 2017-03-08
PCT/US2018/021069 WO2018165108A1 (en) 2017-03-08 2018-03-06 Intradialytic use of sodium thiosulfate

Publications (1)

Publication Number Publication Date
BR112019018646A2 true BR112019018646A2 (pt) 2020-04-07

Family

ID=63446695

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019018646-8A BR112019018646A2 (pt) 2017-03-08 2018-03-06 método para manter os níveis fisiológicos de tiossulfato, método para prevenir enfarte do miocárdio, método para prevenir morte súbita cardíaca, método para prevenir acidente vascular cerebral, método para prevenir doenças cardiovasculares, método para prevenção de pressão alta, método para prevenir a aterosclerose

Country Status (15)

Country Link
US (5) US10744156B2 (enExample)
EP (2) EP3592824B1 (enExample)
JP (3) JP7416622B2 (enExample)
KR (4) KR102758644B1 (enExample)
AR (1) AR111236A1 (enExample)
AU (2) AU2018231072B2 (enExample)
BR (1) BR112019018646A2 (enExample)
CA (1) CA3055107A1 (enExample)
ES (1) ES2992792T3 (enExample)
IL (4) IL302827B2 (enExample)
NZ (1) NZ756704A (enExample)
PH (1) PH12019501971A1 (enExample)
TW (3) TWI789378B (enExample)
WO (1) WO2018165108A1 (enExample)
ZA (2) ZA202105781B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2992792T3 (en) 2017-03-08 2024-12-18 Hope Medical Entpr Inc D B A Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
MD3817751T2 (ro) 2018-07-03 2025-10-31 Fennec Pharmaceuticals Inc Compoziții de tiosulfat de sodiu anhidru
US11850313B2 (en) * 2019-12-20 2023-12-26 The London Health Sciences Centre Research Inc. Method and compositions for protecting tissue
WO2024092228A2 (en) * 2022-10-28 2024-05-02 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Localized delivery of sodium thiosulfate nanoparticles to mitigate arterial calcification
CN116573782B (zh) * 2023-04-03 2023-11-03 迁安市宏奥工贸有限公司 脱硫废液的处理方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341151C (en) 1985-09-10 2000-12-05 Elias Klein Osmotic agents form peritoneal dialysis
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
US6380163B1 (en) 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
FI98538C (fi) * 1993-10-20 1997-07-10 Enso Gutzeit Oy Menetelmä natriumhydroksidin valmistamiseksi valkolipeästä
US6306836B1 (en) 1994-01-21 2001-10-23 Baxter International Inc. Peritoneal dialysis solutions containing maltodextrins and amino acids
US6436969B1 (en) 1995-09-12 2002-08-20 Kansas University Medical Center Research Institute Inc. Dialysis solutions and methods
CA2422850C (en) * 1999-09-22 2009-03-03 Advanced Renal Technologies High citrate dialysate and uses thereof
CA2406081C (en) * 2000-04-26 2009-12-22 Oregon Health Sciences University Administration of a thiol-based chemoprotectant compound
JP4882054B2 (ja) 2000-09-13 2012-02-22 独立行政法人科学技術振興機構 腹膜透析液およびその調製法
CA2537222A1 (en) 2003-07-09 2005-01-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
WO2006001345A1 (ja) 2004-06-23 2006-01-05 Kyowa Hakko Kogyo Co., Ltd. Ｌ－リジン・クエン酸塩結晶
US20070154570A1 (en) 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
US7834065B2 (en) 2005-01-31 2010-11-16 Bmg Incorporated Medical-use two part reactive adhesive and medical-use resin having self-degradation property
US20090304600A1 (en) * 2008-06-09 2009-12-10 Anupkumar Shetty Intradialytic administration of sodium thiosulfate
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
DK2451435T4 (da) 2009-07-08 2022-02-28 Hope Medical Entpr Inc D B A Hope Pharmaceuticals Natriumthiosulfat-indeholdende farmaceutiske sammensætninger
WO2013023217A1 (en) 2011-08-11 2013-02-14 Board Of Regents, The University Of Texas System Method of measuring and monitoring in vivo nitrite levels
AU2013212264B2 (en) 2012-01-23 2017-05-18 Santalis Pharmaceuticals Inc. Sandalwood oil and its uses related to clostridium infections
JP2015516407A (ja) * 2012-05-10 2015-06-11 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 異所性石灰化の治療のためのチオ硫酸ナトリウム
JP5486069B1 (ja) * 2012-11-05 2014-05-07 旭 酒井 透析装置
US20140350097A1 (en) 2013-05-23 2014-11-27 Medinox,Inc. Treatment of hypotension associated with hemodialysis
WO2016094409A1 (en) * 2014-12-09 2016-06-16 Villarreal Anna Methods and devices for female health monitoring
ES2992792T3 (en) 2017-03-08 2024-12-18 Hope Medical Entpr Inc D B A Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
IL301302B2 (en) 2017-03-08 2024-09-01 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Intradialytic use of sodium nitrite

Also Published As

Publication number Publication date
CA3055107A1 (en) 2018-09-13
IL302827B1 (en) 2024-06-01
EP3592824A1 (en) 2020-01-15
EP4403215A3 (en) 2024-10-09
KR102758644B1 (ko) 2025-01-23
US20220031735A1 (en) 2022-02-03
IL295119B1 (en) 2023-06-01
AU2024203603A1 (en) 2024-06-20
ZA202209104B (en) 2024-12-18
EP3592824A4 (en) 2020-12-23
IL295119B2 (en) 2023-10-01
KR102706439B1 (ko) 2024-09-19
JP7416622B2 (ja) 2024-01-17
TWI789378B (zh) 2023-01-11
US10744156B2 (en) 2020-08-18
KR20240139090A (ko) 2024-09-20
AU2018231072A1 (en) 2019-09-19
EP4403215A2 (en) 2024-07-24
IL302827B2 (en) 2024-10-01
IL268883A (en) 2019-10-31
TW202517284A (zh) 2025-05-01
KR20190129911A (ko) 2019-11-20
IL268883B (en) 2022-09-01
KR20240038813A (ko) 2024-03-25
AU2018231072B2 (en) 2024-04-04
KR20250007674A (ko) 2025-01-14
IL295119A (en) 2022-09-01
TWI869743B (zh) 2025-01-11
JP2024045164A (ja) 2024-04-02
NZ756704A (en) 2022-07-01
US12370212B2 (en) 2025-07-29
JP7642878B2 (ja) 2025-03-10
JP2025084833A (ja) 2025-06-03
ZA202105781B (en) 2023-05-31
IL312724A (en) 2024-07-01
TW201840343A (zh) 2018-11-16
IL302827A (en) 2023-07-01
AR111236A1 (es) 2019-06-19
TW202315650A (zh) 2023-04-16
JP2020510680A (ja) 2020-04-09
ES2992792T3 (en) 2024-12-18
US20180256639A1 (en) 2018-09-13
PH12019501971A1 (en) 2020-06-15
KR102647836B1 (ko) 2024-03-15
US11779596B2 (en) 2023-10-10
WO2018165108A1 (en) 2018-09-13
US11116790B2 (en) 2021-09-14
US20250332194A1 (en) 2025-10-30
EP3592824B1 (en) 2024-06-12
US20240100086A1 (en) 2024-03-28
US20200338120A1 (en) 2020-10-29

Similar Documents

Publication Publication Date Title
US12370212B2 (en) Intradialytic use of sodium thiosulfate
JP7765687B2 (ja) 亜硝酸ナトリウムの透析中の使用
NZ788158A (en) Intradialytic use of sodium thiosulfate

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/03/2018, OBSERVADAS AS CONDICOES LEGAIS